FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

27957111000001100: Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Nov 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
87553901000001112 Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106895001000001119 Ziclaseg 30mg modified-release tablets (Lupin Healthcare (UK) Ltd) 28 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Is a Gliclazide 30mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Has AMP Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start